Breaking News on Supplements & Nutrition - North AmericaEU edition

News > Regulation

Dannon on FTC settlement: “Our claims remain intact”

1 commentBy Shane Starling , 16-Dec-2010
Last updated the 16-Dec-2010 at 18:56 GMT

Dannon will continue making digestive health claims for Activia
Dannon will continue making digestive health claims for Activia

Dannon says its year-long negotiations with the Federal Trade Commission that resulted in a $21m settlement and modifications placed on its health statements, has not altered the core claims for its multi-million dollar selling probiotic yoghurts.

The North American subsidiary of French dairy giant Danone said it would continue marketing spoonable yogurt Activia with digestive health claims and linking drinkable yogurt DanActiv with immunity.

“After three rigorous reviews we continue to market the products as per usual,” Dannon spokesperson Michael Neuwirth told NutraIngredients-USA.com, while highlighting the fact Dannon admitted no wrongdoing in the settlement.

He said the $21m figure was arrived at to reimburse 39 state Attorney Generals who had conducted investigations into Dannon’s marketing activities, but which were now resolved.

Neuwirth noted only $1m had been claimed of a potential fund of $35m that had been established in a 2009 class action settlement, although the remainder of the fund would be paid to charities beginning in 2011.

New claims criteria

The FTC settlement highlighted that Activia could only be marketed to, relieve temporary irregularity or help with slow intestinal transit time” if it was also stated that three servings per day were required to achieve the benefit.

Neuwirth said Dannon “may well use” such a claim.

Otherwise the FTC reiterated a two well-designed human clinical studies” claim substantiation standard expressed in earlier settlements with Nestle and Iovate Health Sciences, if Dannon wanted to make the claims without the ‘three servings pr day’ disclaimer.

Under other terms of the settlement Dannon must not claim, “that any yogurt, dairy drink, or probiotic food or drink reduces the likelihood of getting a cold or the flu, unless the claim is approved by the Food and Drug Administration.”

While forming part of the settlement Dannon insisted it had never made such claims.

Ingredients versus products

New York-based food and drug attorney, Marc Ullman, said the settlement demonstrated how refined the art of claim making was becoming as both the FDA and FTC directed greater scrutiny upon them.

“This is a reminder that if you are going to claim that your product is clinically proven to do something, then you need clinical studies on the product,” he said. “If all you have are studies on the ingredients, then you need to say so. If all you have are in vitro or animal studies, then you can’t claim to have clinical studies.”

“I certainly don’t know enough about Dannon’s science to comment, though I would imagine that the company would have contested the matter more rigorously if it had human trials on its specific product that directly supported its claims.”

Ullman said the settlement even favoured Dannon in that there was no requirement for financial restitution.

“I think that industry needs to be concerned about the FTC’s disparate treatment of small as opposed to large companies, as its posture toward smaller companies has been one of utter inflexibility and refusal to compromise.”

Chilling effect on speech

Virginia-based attorney Jonathan Emord said the settlement reflected a level of scientific substantiation that was amounting to censorship of health benefit advice to the public.

“If the evidence is credible, but not conclusive, the consumer is best served not by government intimidating parties into saying nothing but by government requiring use of a claim qualification revealing the inconclusiveness of the claim. The FTC’s method causes a chilling effect on speech by all in the market just as powerful as if it imposed a prior restraint.”

He added: “The real losers in all of this are consumers. Denied credible science, they will be left to guess about whether Dannon’s product provides any benefits. Moreover, Dannon will now have no incentive to invest in further research to improve upon the health enhancing effects of its products.”

In the settlement, FTC Chairman Jon Leibowitz said: “These types of misleading claims are enough to give consumers indigestion. Consumers want, and are entitled to, accurate information when it comes to their health. Companies like Dannon shouldn’t exaggerate the strength of scientific support for their products.”

The settlement can be found here.

1 comment (Comments are now closed)

Shame on the FTC

Long story short.....immunity claims and yogurt go together....half of the body torso is the digestive system.....a sluggish system and filled with bad bacteria does drop the immunity level and help breed disease, too. It does not take NASA Science to figure the health claims out.
The FTC behavior and the Attorney General sparked a response from a few Congressmen to over regulating and big government taking advantage of their power.
3 generations of my family have consumed yogurt and we are in good health and rarely ever have the sniffles or a cold or constipation.
Why doesn't the FTC regulate milk from China and question the strains of bacteria in that milk.
No shame on em! The FTC and the stupidity of the FDA never ends.....I think American's need to stand up and declare their efferts and findings unconstitutional, too.
What is clear to me is that the natural food industry is being targeted unfairly and pushing Congress....it is all about the money.

Report abuse

Posted by Sandi
18 December 2010 | 00h49

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...